PIRAMAL PHARMA
|
The Current P/E Ratio of PIRAMAL PHARMA is 1,501.56.
Share Price | ₹205.6 | Jun 02,2025 |
Market Cap | ₹27,328.4 Cr | |
Earnings-TTM | ₹18.2 Cr | TTM-Consolidated Results |
Price/Earnings | 1,501.56x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of PIRAMAL PHARMA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹27,328.4 Cr] as on Jun 02,2025
(/) Earnings [ ₹18.2 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 1,501.56x ]
Thus, for PIRAMAL PHARMA , the investors are currently willing to pay 1,501.56 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of PIRAMAL PHARMA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of PIRAMAL PHARMA over the last five years.
Historical PE (Price/Earnings) ratio chart of PIRAMAL PHARMA
PE Ratio Performance Analysis for PIRAMAL PHARMA
- PIRAMAL PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2021 averaged 239.24x.
- PIRAMAL PHARMA 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 4 fiscal years, PIRAMAL PHARMA 's p/e ratio peaked in Mar2024 at 956.94x.
- PIRAMAL PHARMA 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does PIRAMAL PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
PIRAMAL PHARMA | 18.20 | 1,501.56 | 27,328.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,980.10 | 36.60 | 401,865.0 |
DIVIS LABORATORIES LTD | 2,191.00 | 79.22 | 173,574.0 |
CIPLA LTD | 5,291.05 | 22.44 | 118,710.0 |
TORRENT PHARMACEUTICALS LTD | 1,911.00 | 55.45 | 105,964.0 |
DR REDDYS LABORATORIES LTD | 5,703.50 | 18.28 | 104,232.0 |
MANKIND PHARMA LTD | 2,003.22 | 49.73 | 99,618.8 |
ZYDUS LIFESCIENCES LTD | 4,614.80 | 20.26 | 93,474.1 |
LUPIN LTD | 3,306.26 | 27.07 | 89,505.5 |
AUROBINDO PHARMA LTD | 3,515.26 | 18.77 | 65,993.6 |
ABBOTT INDIA LTD | 1,414.44 | 46.07 | 65,158.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs PIRAMAL PHARMA 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 1.00x |
Max industry PE | 79.22x |
Median industry PE | 27.07x |
Average industry PE | 34.08x |
You may also like the below Video Courses